Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2006 1
2008 3
2009 4
2011 1
2012 3
2013 4
2014 5
2015 6
2016 11
2017 15
2018 18
2019 11
2020 9
2021 17
2022 17
2023 20
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Grebely J, Dalgard O, Conway B, Cunningham EB, Bruggmann P, Hajarizadeh B, Amin J, Bruneau J, Hellard M, Litwin AH, Marks P, Quiene S, Siriragavan S, Applegate TL, Swan T, Byrne J, Lacalamita M, Dunlop A, Matthews GV, Powis J, Shaw D, Thurnheer MC, Weltman M, Kronborg I, Cooper C, Feld JJ, Fraser C, Dillon JF, Read P, Gane E, Dore GJ; SIMPLIFY Study Group. Grebely J, et al. Among authors: hajarizadeh b. Lancet Gastroenterol Hepatol. 2018 Mar;3(3):153-161. doi: 10.1016/S2468-1253(17)30404-1. Epub 2018 Jan 6. Lancet Gastroenterol Hepatol. 2018. PMID: 29310928 Free article. Clinical Trial.
Hepatitis C elimination in Australia: progress and challenges.
Martinello M, Hajarizadeh B, Dore GJ. Martinello M, et al. Among authors: hajarizadeh b. Med J Aust. 2020 May;212(8):362-363. doi: 10.5694/mja2.50584. Epub 2020 Apr 19. Med J Aust. 2020. PMID: 32306399 No abstract available.
Epidemiology and natural history of HCV infection.
Hajarizadeh B, Grebely J, Dore GJ. Hajarizadeh B, et al. Nat Rev Gastroenterol Hepatol. 2013 Sep;10(9):553-62. doi: 10.1038/nrgastro.2013.107. Epub 2013 Jul 2. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23817321 Review.
Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs.
Grebely J, Collins AB, Artenie AA, Sutherland R, Meyer JP, Barocas JA, Falade-Nwulia O, Cepeda JA, Cunningham EB, Hajarizadeh B, Lafferty L, Lazarus JV, Bonn M, Marshall AD, Treloar C. Grebely J, et al. Among authors: hajarizadeh b. Int J Drug Policy. 2021 Oct;96:103469. doi: 10.1016/j.drugpo.2021.103469. Epub 2021 Oct 2. Int J Drug Policy. 2021. PMID: 34610884 No abstract available.
136 results